#+startup: beamer
#+TITLE: Striatal volume and functional connectivity predict weight gain
#+TITLE: in early-phase psychosis
* Preamble                                                    :ignore:
** General comments                                           :ignore:
# ----------------------------------------------------------------------
# - Turn on synonyms by starting synosaurus-mode
# - Look up words using C-c sr
# - Turn on dictionary by starting flyspell-mode
# - Count words by section using org-wc-display
# ----------------------------------------------------------------------
** Specific comments for this manuscript                       :ignore:
# ----------------------------------------------------------------------
** org specific settings                                        :ignore:
# ----------------------------------------------------------------------
#+OPTIONS: email:nil toc:nil num:nil author:nil date:t tex:t title:nil
#+STARTUP: align fold
#+SEQ_TODO: TODO(t) | DONE(d)
#+TAGS: figure(f) check(c) noexport(n) ignore(i)
#+LANGUAGE: en
#+EXCLUDE_TAGS: noexport TODO
#+DATE: {{{time(%Y-%m-%d %H:%M)}}}
# ----------------------------------------------------------------------
** Latex header                                                 :ignore:
# ----------------------------------------------------------------------
#+LATEX_CLASS:  mybeamerposter
#+LATEX_HEADER:  \setlength{\paperwidth}{36in}
#+LATEX_HEADER:  \setlength{\paperheight}{48in}
# LATEX_HEADER: \setlength{\textwidth}{0.98\paperwidth}
# LATEX_HEADER: \setlength{\textheight}{0.98\paperheight}
# LATEX_HEADER: \usepackage[absolute,overlay]{textpos}
#+LATEX_HEADER: \graphicspath{{../output/figures/}{../lib/}}
#+LATEX_HEADER: \usepackage[export]{adjustbox}
#+LATEX_HEADER: \usepackage{graphicx,caption}
#+LATEX_HEADER: \usepackage{eurosym}
#+LATEX_HEADER: \usepackage{textcomp}
#+LATEX_HEADER: \usepackage{bibentry}
# LATEX_HEADER: \setlength{\TPVertModule}{1cm}
# LATEX_HEADER: \setlength{\oddsidemargin}{0.1in} 
# LATEX_HEADER: \title{The demise of the spotted swamp frog}
# LATEX_HEADER: \author{Rob J Hyndman}
# LATEX_HEADER: \footer{
# LATEX_HEADER: \textbf{Philipp Homan, MD, PhD}\\
# LATEX_HEADER: phoman1@northwell.edu\\
# LATEX_HEADER: github.com/philipphoman}
#+LATEX_HEADER: \date{}
# ----------------------------------------------------------------------
** Latex macros                                               :ignore:
# ----------------------------------------------------------------------
#+LATEX_HEADER: \newcommand{\auth}{$^{\ast}$Philipp Homan, MD, PhD}
#+LATEX_HEADER: \newcommand{\authemail}{phoman1@northwell.edu}
#+LATEX_HEADER: \newcommand{\authtwitter}{@philipphoman}
#+LATEX_HEADER: \newcommand{\authgithub}{github.com/philipphoman}
# ----------------------------------------------------------------------
** Authors and affiliations                                     :ignore:
# ----------------------------------------------------------------------
#+LATEX_HEADER: \author{
#+LATEX_HEADER: Philipp Homan$^{1\ast}$, 
#+LATEX_HEADER: Christina Fales$^{1}$, 
#+LATEX_HEADER: Pamela DeRosse$^{1}$, 
#+LATEX_HEADER: Philip Szeszko$^{1}$, 
#+LATEX_HEADER: Delbert Robinson$^{1}$,   
#+LATEX_HEADER: Todd Lencz$^{1}$, 
#+LATEX_HEADER: Anil K. Malhotra$^{1}$
#+LATEX_HEADER: \\
#+LATEX_HEADER: \vspace{5mm}
#+LATEX_HEADER: \normalsize{$^{1}$Department of Psychiatry,} 
#+LATEX_HEADER: \normalsize{The Donald and Barbara Zucker}
#+LATEX_HEADER: \normalsize{School of Medicine at Northwell/Hofstra,}
#+LATEX_HEADER: \normalsize{Hempstead, NY}\\
#+LATEX_HEADER: }
# ----------------------------------------------------------------------
** Buffer-wide source code blocks                               :ignore:
# ----------------------------------------------------------------------
# Set elisp variables need for nice formatting We want no new lines in
# inline results and a paragraph size of 80 characters Important: this
# has to be evaluated witch C-c C-c in order to work in the current
# buffer
#+BEGIN_SRC emacs-lisp :exports none :results silent

; set timestamp format
;(setq org-export-date-timestamp-format "%FT%T%z")
(require 'org-wc)
(flyspell-mode t)
;(evil-declare-change-repeat 'company-complete)
(setq synosaurus-choose-method 'popup)
(synosaurus-mode t)
(auto-complete-mode t)
;(ac-config-default)
;(add-to-list 'ac-modes 'org-mode)
(linum-mode t)
(whitespace-mode t)
(setq org-babel-inline-result-wrap "%s")
(setq org-export-with-broken-links "mark")
(setq fill-column 72)
(setq whitespace-line-column 72)
;(setq org-latex-caption-above '(table image))
(setq org-latex-caption-above nil)
(org-toggle-link-display)
; don't remove logfiles at export
(setq org-latex-remove-logfiles nil)

; Keybindings
; (global-set-key (kbd "<f7> c") "#+CAPTION: ")
(defun setfillcolumn72 ()
	 (interactive)
   (setq fill-column 72)
	 )

(defun setfillcolumn42 ()
	 (interactive)
   (setq fill-column 42)
 )
(define-key org-mode-map (kbd "C-c c #") "#+CAPTION: ")
(define-key org-mode-map (kbd "C-c l #") "#+LATEX_HEADER: ")
(define-key org-mode-map (kbd "C-c f c 4 2") 'setfillcolumn42)
(define-key org-mode-map (kbd "C-c f c 7 2") 'setfillcolumn72)

(setq org-odt-category-map-alist
    '(("__Figure__" "*Figure*" "value" "Figure" org-odt--enumerable-image-p)))


; let ess not ask for starting directory
(setq ess-ask-for-ess-directory nil)

;(setq org-latex-pdf-process '("latexmk -pdflatex='xelatex
;-output-directory=../output/tex/ -interaction nonstopmode' -pdf
;-bibtex -f %f"))
(setq org-latex-logfiles-extensions 
    (quote("bcf" "blg" "fdb_latexmk" "fls" 
    "figlist" "idx" "log" "nav" "out" "ptc" 
    "run.xml" "snm" "toc" "vrb" "xdv")))

; deactivate link resolving
(setq org-activate-links nil)

; set tags identation
(setq org-tags-column -72)

#+END_SRC
#
#
#
# ----------------------------------------------------------------------
** End preamble                                                 :ignore:
# ----------------------------------------------------------------------

* References                                                    :ignore:
\bibliographystyle{nature}
\nobibliography{master} 
* The poster
:PROPERTIES:
:BEGIN:
:BEAMER_env: fullframe
:END:

** Code                                                       :ignore:
# First, make sure all variables are availabe
#+HEADER: :exports none
#+BEGIN_SRC R :results silent :session
if (!(grepl("src", getwd())))
  setwd("../../../../src")
source("fe_func.R")
source("bmi_load.R")

# R version
rvers <- version$version.string

# Python version
# pyvers <- system("python --version")
# pysurfvers <- system("pip freeze | grep pysurf")
#pyvers <- "2.7.13"
#pysurfvers <- "0.7"
pyplusvers <- system("pyv=$(python -V 2>&1); echo $pyv", intern=TRUE)
pysurfplusvers <- system("pip list | grep pysurf", intern=TRUE)

#+END_SRC

** Left column                                                  :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.45
:BEAMER_opt: [t]
:END:
*** Background                                                 :B_block:
:PROPERTIES:
:BEAMER_env: block
:END:
- Schizophrenia has long been considered a disorder of dysconnectivity
  in the brain
- Using graph theory, we computed statistical similarity networks for
  each individual (Fig [[figflowchart]], [[figshrinkage]]) in two
  early-phase schizophrenia cohorts src_R[:session]{parse_n("sz")}
  {{{results((/N/ = 82))}}} and in healthy controls
  src_R[:session]{parse_n("hc")} {{{results((/N/ = 77))}}} and tested
  whether network architecture predicted treatment response

*** Methods: Structural similarity networks                    :B_block:
:PROPERTIES:
:BEAMER_env: block
:END:

\captionsetup{justification=justified,width=.85\linewidth}
#+NAME: figflowchart
#+CAPTION: *Analysis flow chart.*
#+CAPTION: The similarity between any pair of region was
#+CAPTION: estimated by calculating the
#+CAPTION: Kullback-Leibler (KL) divergence of their
#+CAPTION: probability distributions, resulting in 
#+CAPTION: a similarity matrix. 
#+CAPTION: The similarity matrix 
#+CAPTION: was then thresholded into a binary matrix to 
#+CAPTION: create a network graph. Graph-based 
#+CAPTION: degree (or hubness) for each node was then
#+CAPTION: calculated for each individual participant. 
#+CAPTION: Nodal degrees were then entered as
#+CAPTION: predictors into a partial
#+CAPTION: least squares regression, using individual
#+CAPTION: treatment response slopes as outcome
#+CAPTION: measure.
#+ATTR_LATEX: :width 0.85\textwidth 
[[file:fe_freesurfer_flowchart.pdf]]

*** Methods: Individual treatment response                     :B_block:
:PROPERTIES:
:BEAMER_env: block
:END:

\captionsetup{justification=justified,width=.85\linewidth}
#+NAME: figshrinkage
#+CAPTION: *Partial pooling to regularize individual response slopes.* 
#+CAPTION: *A.* *Individual time courses for all participants*
#+CAPTION: *from the first schizophrenia cohort.* 
#+CAPTION: Partial pooling regularized
#+CAPTION: the individual slopes, i.e., the influence
#+CAPTION: of outliers with only few assessments was attenuated. 
#+CAPTION: *B.* *The partial pooling effect*
#+CAPTION: *is demonstrated by the individual responses being*
#+CAPTION: *pulled toward the average treatment effect.*
#+CAPTION: As a consequence, outliers are less influential.
#+CAPTION: *C, D. The same is shown for the second schizophrenia*
#+CAPTION: *cohort.*
#+CAPTION: Dotted ellipses indicate confidence regions for the
#+CAPTION: average treatment effect.
#+ATTR_LATEX: :width 0.85\textwidth
[[file:fe_freesurfer_shrinkage.pdf]]

** Right column                                                 :BMCOL:
:PROPERTIES:
:BEAMER_col: 0.45
:BEAMER_opt: [t]
:END:
*** Results: Partial least squares regression                  :B_block:
:PROPERTIES:
:BEAMER_env: block
:END:

- Individual differences in the configuration of structural similarity
  networks explained a significant proportion of variance in treatment
  response (Fig. [[figplsbrains]])
- Exploratory analysis: increased clustering and decreased network
  integration in patients compared to controls (Fig. [[figge]])

\captionsetup{justification=justified,width=.8\linewidth}
#+NAME: figplsbrains
#+CAPTION: *PLS scores with individual treatment* 
#+CAPTION: *response and contribution of cortical nodes*
#+CAPTION: *in the schizophrenia cohort*
#+CAPTION: Nodal degree for each of 
#+CAPTION: the src_R[:session]{n_nodes} {{{results(68)}}}
#+CAPTION: was entered into a partial least squares (PLS) 
#+CAPTION: regression, with individual treatment response 
#+CAPTION: slopes as outcome measure. The first two
#+CAPTION: PLS components explained a significant proportion
#+CAPTION: of variance in treatment response. *A, B. The first*
#+CAPTION: *PLS component correlated most strongly with*
#+CAPTION: *nodal degree of orbito- and prefrontal cortices*
#+CAPTION: *and posterior cingulate cortex.* Note that
#+CAPTION: more negative slopes meant better
#+CAPTION: treatment response. 
#+CAPTION: *B, C. The second PLS component correlated most*
#+CAPTION: *most strongly with superior temporal, precentral,*
#+CAPTION: *and middle cingulate brain areas.*
#+ATTR_LATEX: :width 0.8\textwidth
[[file:fe_freesurfer_plsbrains.pdf]]

*** Results: Increased clustering in patients                  :B_block:
:PROPERTIES:
:BEAMER_env: block
:END:

\captionsetup{justification=justified,width=0.8\linewidth}
#+NAME: figge
#+CAPTION: *A. Decreased network integration in*
#+CAPTION: *schizophrenia patients compared to controls.*
#+CAPTION: Means with error bands
#+CAPTION: are shown.
#+CAPTION: *B. Increased clustering in schizophrenia patients*
#+CAPTION: *compared to controls.*
#+CAPTION: Means with error bands are shown.
#+CAPTION: Non-overlapping error bands 
#+CAPTION: indicate significant group differences (/P/ < 0.05).
#+ATTR_LATEX: :width 0.8\textwidth 
[[file:fe_freesurfer_graphsum_individual_2plots.pdf]]

*** Conclusions                                                :B_block:
:PROPERTIES:
:BEAMER_env: block
:END:
- These data suggest a potential link between brain network morphology
  and clinical outcome in early-phase schizophrenia

*** Disclosure                                                 :B_block:
:PROPERTIES:
:BEAMER_env: block
:END:

\tiny
Dr. Robinson has served as a consultant for Asubio, Otsuka, and Shire
and has received grants from Bristol-Myers Squibb, Janssen, and
Otsuka. Dr. Kane has served as a consultant for Alkermes, Eli Lilly,
Forest, Forum, Genentech, Intracellular Therapies, Janssen, Johnson &
Johnson, Lundbeck, Otsuka, Reviva, Roche, Sunovion, and Teva; he has
received honoraria for lectures from Genentech, Janssen, Lundbeck, and
Otsuka; and he is a shareholder in MedAvante and Vanguard Research
Group. Dr. Lencz is a consultant for Genomind. Dr. Malhotra has served
as a consultant for Forum Pharmaceuticals and has served on a scientific
advisory board for Genomind. The other authors report no financial
relationships with commercial interests.
